KalVista Pharmaceuticals, Inc. (KALV)

NASDAQ: KALV · Real-Time Price · USD

20.29

+0.70 (3.57%)

At close: Apr 14, 2026, 4:00 PM EDT

20.29

0.00 (0.00%)

After-hours: Apr 14, 2026, 4:10 PM EDT

KalVista Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023
Period Ending	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024
Selling, General & Admin	116.29	54.28
Research & Development	71.71	86.17
Total Operating Expenses	188	140.45
Operating Income	-188	-140.45
Interest Income	6.44	3.9
Interest Expense	-5.79	-
Other Non-Operating Income (Expense)	7.29	9.91
Total Non-Operating Income (Expense)	7.94	13.8
Pretax Income	-180.05	-126.64
Provision for Income Taxes	3.39	-
Net Income	-183.44	-126.64
Net Income to Common	-183.44	-126.64
Shares Outstanding (Basic)	50	37
Shares Outstanding (Diluted)	50	37
Shares Change (YoY)	34.98%	-
EPS (Basic)	-3.69	-3.44
EPS (Diluted)	-3.69	-3.44
Shares Outstanding	49.76	42.52
Free Cash Flow	-153.34	-89.27
Free Cash Flow Per Share	-3.09	-2.43
EBITDA	-187.05	-139.63
EBIT	-188	-140.45
Effective Tax Rate	-1.88%	0.00%

Updated Nov 10, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q